Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial.
Microvesicles: novel biomarkers for neurological disorders.
Modulation of Sox10, HIF-1α, Survivin, and YAP by Minocycline in the Treatment of Neurodevelopmental Handicaps following Hypoxic Insult.
[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection].
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
Early activation of CD4+ and CD8+ T lymphocytes by myelin basic protein in subjects with MS.
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.
Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial.
Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia.
Don't stress about it!: Is stress management a disease-modifying therapy for multiple sclerosis?
Excess of melanocytic nevi in a patient treated with natalizumab for multiple sclerosis.
Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab.
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
The impact of environmental infections (parasites) on MS activity.
Disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study.
Food and Drug Administration briefing document for ofatumumab
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study.
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
Animal Models in Neurology: Drawbacks and Opportunities.
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease.
Low-contrast visual tests reveal better alemtuzumab efficacy
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Reproductive issues in women with multiple sclerosis: ethical considerations.
Physiopathology of symptoms and signs in multiple sclerosis.

Pages